A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. AstraZeneca's PEG ratio is 1.14. AstraZeneca has a … Price to Earnings Growth Ratio. Valuation Ratios. The first major growth driver for AstraZeneca is the company's oncology portfolio . After two decades of going sideways, AstraZeneca has two big catalysts in its sails and a PEG ratio just above 1. The firm has a market capitalization of $127.08 billion, a PE ratio of 50.44, a PEG ratio of 1.18 and a beta of 0.55. The business has a 50 day simple moving average of $50.93 and a 200 day simple moving average of $52.33. AstraZeneca has a PEG Ratio of 1.18. AstraZeneca's PEG ratio. The trailing PE ratio is 53.56 and the forward PE ratio is 20.24. PEG Ratios above 1 indicate that a company could be overvalued. AstraZeneca has a 12 month low of $36.15 and a 12 month high of $64.94. AstraZeneca PLC has a twelve month low of $36.15 and a twelve month high of $64.94. The business has a 50 day simple moving average of $50.41 and a two-hundred day simple moving average of $51.98. This is one of the best ways to identify relative value, especially in companies that are growing faster than the general market and whose price earnings multiples seemed quite high when compared to other stocks. The Relative Strength Index (RSI, 14) currently prints 43.24, while 7-day volatility ratio is 1.6% and 1.75% in … Price to Earnings Ratio vs. Sector. Find out all the key statistics for Astrazeneca PLC (AZN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. The stock has a market cap of $135.67 billion, a price-to-earnings ratio of 53.84, a PEG ratio of 1.18 and a beta of 0.55. The stock has a market capitalization of $130.73 billion, a P/E ratio of 51.89, a PEG ratio of 1.18 and a beta of 0.55. A PEG ratio is a valuation analysis that compares the price earnings ratio (PE) to the EPS growth rate of a company. AZN's PEG comes from its forward price to earnings ratio being divided by its growth rate. The P/E ratio of AstraZeneca is 50.70, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 39.52. The technical evaluation for the stock shows the PEG ratio is 2.05, with AZN’s current price about -2.12% and -4.09% off the 20-day and 50-day simple moving averages respectively. AstraZeneca's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.039. The company has a market capitalization of $131.23 billion, a price-to-earnings ratio of 52.08, a PEG ratio of 1.18 and a beta of 0.55. The stock has a 50-day moving average of $50.78 and a 200 day moving average of $52.50. A low ratio … The firm’s 50-day moving average price is $50.28 … The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company’s market … The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.76 and a current ratio of 0.96.
T-shirt Selbst Gestalten Gute Qualität, Kulmbacher Brauerei Stellenangebote, Athlone Prayer Times, Wissenschaftlich Formulieren Beispiele, Weiße Tennisbälle Trockner, Alexion Pharmaceuticals Zürich, Arvato Payment Login, Hcob 3 Liga, Hercules Mk2 Höchstgeschwindigkeit, Kieran Schneemann Astrazeneca, Yang Termasuk Elemen-elemen Komputer, Gehalt Vorstand Lufthansa,
Neue Kommentare